Ultra-Sensitive Fluorimetric Method for the First Estimation of Vonoprazan in Real Human Plasma and Content Uniformity Test

Journal of Fluorescence - Vonoprazan (VON) has been approved recently via US-FDA in 2015 as the first in class of potassium competitive acid blocker group. VON is used for management of...     

Eco-friendly micellar HPTLC technique for the simultaneous analysis of co-formulated antibiotic cefoperazone and sulbactam in pure form and vial pharmaceutical formulation

JPC – Journal of Planar Chromatography – Modern TLC - A rapid, sensitive, and eco-friendly micellar high-performance thin-layer chromatography (HPTLC) technique for the simultaneous...     

Highly sensitive high-performance thin-layer chromatography method for the simultaneous determination of molnupiravir,favipiravir, and ritonavir in pure forms and pharmaceutical formulations

Favipiravir, molnupiravir, and ritonavir have been recently approved as the first oral antivirals for treatment of SARS-CoV-2 viral infections. Their combination was reported in several clinical studies, alternatively, to enhance the viral eradication and improve patient's recovery times and rates. Being all orally administered, therefore, the development of new sensitive and validated methodologies for their simultaneous determination is a necessitate. In the proposed research, a sensitive, selective, and simple high-performance thin layer chromatography method was developed and validated for determination of favipiravir, molnupiravir, and ritonavir. Silica gel 60F254 thin layer chromatography plates were used as stationary phase for this separation using mobile phase composed of methylene chloride:ethyl acetate:methanol:25% ammonia (6:3:4:1, v/v/v/v). Densitometric detection was performed at wavelength 289 nm. Peaks of favipiravir, molnupiravir, and ritonavir were resolved at retention factors 0.22, 0.42, and 0.63, respectively. The proposed method was found linear within the specified ranges of 3.75–100.00 μg/mL for molnupiravir and favipiravir, and 2.75–100.00 μg/mL for ritonavir. Limits of detection were found to be 1.12, 1.21, and 0.89 μg/mL for favipiravir, molnupiravir, and ritonavir, respectively. This is the first method to be reported for the simultaneous determination of the cited three antiviral drugs. The method was assessed on novel greenness metrics.     

Simultaneous High-Performance Thin-Layer Chromatographic Determination of Ondansetron and Pantoprazole in Their Pure Forms and Spiked Human Plasma

JPC – Journal of Planar Chromatography – Modern TLC - The therapeutic combination of ondansetron (OND) and pantoprazole (PAN) is widely prescribed for the treatment of many...     

Development of a High-Performance Thin-Layer Chromatographic Method for the Simultaneous Determination of Newly Co-formulated Antiviral Drugs Sofosbuvir and Velpatasvir in Their Pure Forms and Tablet Dosage Form

JPC – Journal of Planar Chromatography – Modern TLC - The discovery of new direct-acting antiviral drugs gave rise to a leap forward in the treatment of hepatitis C viral infections....     

Application of the green analytical procedure index to the simultaneous analysis of co-formulated tinidazole and ciprofloxacin in pure form,tablet dosage form,and human plasma using an environmentally friendly micellar high-performance thin-layer chromatographic technology

JPC – Journal of Planar Chromatography – Modern TLC - In individuals with chronic refractory pouchitis and other gastrointestinal disorders, the combination of ciprofloxacin (CIP) and...